Sydney Vital supported Dr David Chan’s attendance to the Congress of the World Federation of Nuclear Medicine and Biology 2018 (WFNMB), this was the 12th congress held in Melbourne, Australia.
The event attracted nuclear medicine physicians, radiologists, medical imaging trainees, physicists, scientists, technologists, nurses and the broader medical scientific community. With the aim to promote further global transactions of molecular medicine incorporating the translation of basic laboratory research to clinical practice and establishment of clinical and technical standards, it provided Dr Chan with the opportunity to showcase his research as a part of a presentation.
The research presented by Dr David Chan was a 3-part symposium in neuroendocrine tumour, including representatives from Royal North Shore Hospital, the Peter MacCullum Cancer Centre and the Zentralkinik Bad Berka. Several systematic reviews/meta-analyses in neuroendocrine tumours performed by the neuroendocrine tumour group in Royal North Shore Hospital were cited as part of the presentation. Furthermore, the ground-breaking research in dual NET grading (the NETPET score, Chan…Bailey Theranostics 2017) was highlighted later in the same session by Dr Singh of the Bad Berka centre.
The program of the WFNMB involved a range of focused plenary sessions, continuing education sessions and a large poster presentation sessions which allowed Dr Chan to gain insight into the latest research.
Keep up-to-date with our scholarships, funding and awards and check out our grant schemes.
Dr David Chan